Participants taking semaglutide reported gastrointestinal side effects, such as nausea, more often than those taking a placebo
However, there is research in progress to see whether the drug has long-term effects, like damage to the thyroid or gastrointestinal tract.
Semaglutide helps to increase the amount of GLP-1 in the body, which in turn boosts insulin production
The HISTORI trial tested whether semaglutide could safely improve metabolic health in patients with schizophrenia without worsening psychiatric stability
After first use: Store up to 56 days at controlled room temperature (15C to 30C [59F to 86F]) or in a refrigerator (2C to 8C [36F to 46F])
Therapeutic potential of semaglutide, a newer glp-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: a narrative review